تخطى إلى المحتوى / Skip to content

Try TabeebPlus fully for 7 days free!

Evidence Grade Ascreening

MMSE — Mini-Mental State Examination

The Mini-Mental State Examination (MMSE) is a 30-point cognitive screening tool widely used in clinical and research settings to assess cognitive impairment and track dementia progression over time.

Patient Parameters

Enter the values below to calculate the score.

0
05
Year, season, date, day, month
0
05
State, county, town, hospital/floor, floor
0
03
Repeat 3 words after examiner (apple, penny, table)
0
05
Serial 7s subtraction or WORLD backwards
0
03
Recall the 3 words from registration
0
08
Naming, repetition, 3-step command, reading, writing
0
01
Copy intersecting pentagons

About

The Mini-Mental State Examination (MMSE) was developed by Dr. Marshal Folstein and colleagues in 1975 and has become the most widely used cognitive screening instrument worldwide. It assesses 7 cognitive domains: orientation to time (5 points), orientation to place (5 points), registration of 3 words (3 points), attention and calculation (5 points via serial 7s or WORLD backwards), recall of 3 words (3 points), language (8 points covering naming, repetition, 3-step command, reading, writing, and sentence construction), and visuospatial ability (1 point via intersecting pentagons copy). Total scores range from 0-30, with lower scores indicating greater impairment. The MMSE requires approximately 5-10 minutes to administer. It has been translated and validated in over 60 languages. Key limitations include ceiling effects in highly educated populations (poor sensitivity for MCI) and floor effects in advanced dementia. The MMSE is sensitive to right hemisphere lesions and may miss frontal lobe dysfunction. Scores are influenced by age, education, and cultural background, necessitating normative adjustments. The MMSE is copyright-protected (Psychological Assessment Resources, PAR) and requires a licensing fee for routine clinical use in many settings, which has led to the development of freely available alternatives like the MoCA and Mini-Cog.

Formula

Total = Orientation (Time 0-5 + Place 0-5) + Registration (0-3) + Attention/Calculation (0-5) + Recall (0-3) + Language (0-8) + Visuospatial (0-1). Max 30.

The MMSE total score is computed by summing scores across 7 cognitive domains. Orientation (10 points): 5 for time (year, season, date, day, month) and 5 for place (state, county, town, hospital, floor). Registration (3 points): repeating 3 words (apple, penny, table) after examiner says them once. Attention/Calculation (5 points): serial 7s subtraction (93, 86, 79, 72, 65) or spelling WORLD backwards (DLROW). Recall (3 points): recalling the 3 words learned in registration. Language (8 points): naming a pencil and watch (2), repeating "no ifs, ands, or buts" (1), 3-step command (3 — take paper in right hand, fold it, put it on floor), reading "CLOSE YOUR EYES" (1), writing a sentence (1), and copying intersecting pentagons (1). Total scores range from 0-30. Severity: 24-30 normal, 18-23 mild impairment, 10-17 moderate impairment, 0-9 severe impairment. A decline of 3-4 points over 2 years is considered clinically significant in dementia monitoring.

Score Interpretation

The MMSE is the most established cognitive screening tool in clinical medicine, with over 50 years of clinical use. Its widespread adoption has enabled standardized cognitive assessment across healthcare settings globally. The MMSE is embedded in major clinical guidelines including the NICE dementia guidelines, the American Academy of Neurology practice parameters, and the Alzheimer's Association diagnostic criteria. Serial MMSE measurements are used to track dementia progression, with an expected decline of 2-4 points per year in Alzheimer's disease. The MMSE is also used as a cognitive outcome measure in clinical trials. Important limitations include poor sensitivity for MCI (ceiling effect in highly educated individuals), cultural and educational bias, copyright restrictions requiring licensing fees, and limited assessment of executive function and visuospatial skills.

Severe Impairment0–9

Severe cognitive impairment. Requires full-time care and supervision.

Management: Urgent neurology referral. Full dementia workup. Safety assessment, caregiver support, and long-term care planning.

Moderate Impairment10–17

Moderate cognitive impairment. Supervision and assistance with daily activities may be needed.

Management: Neurology referral for comprehensive evaluation. Assess driving safety and need for supervision.

Mild Impairment18–23

Mild cognitive impairment. Further evaluation recommended.

Management: Consider neuropsychological evaluation. Assess for reversible causes. Monitor for progression.

Normal24–30

Normal cognitive function for age and education.

Management: No further evaluation indicated. Reassess if concerns develop.

Reference Ranges

PopulationNormal RangeNotes
Adults (18+ years)24-30 — NormalNormal cognitive function
Adults (18+ years)18-23 — MildMild cognitive impairment
Adults (18+ years)10-17 — ModerateModerate cognitive impairment
Adults (18+ years)0-9 — SevereSevere cognitive impairment
Dr. Mahmoud El-Sayed, MD, Neurology Specialist

Dr. Mahmoud El-Sayed, MD, Neurology Specialist

MDNeurology

Dr. Mahmoud El-Sayed is a neurology consultant with expertise in cognitive disorders and dementia.

View medical review board & editorial policy →

Example Calculation

An 80-year-old woman with 8 years of education is brought to clinic by her daughter who reports progressive memory decline over 2 years. MMSE results: Orientation Time: 3/5 (knew year and month but not date, season, or day), Orientation Place: 4/5 (knew state, town, hospital, floor but not county), Registration: 3/3, Attention/Calculation: 3/5 (serial 7s: 93, 86, 79, stopped), Recall: 1/3 (recalled 1 of 3 words), Language: 7/8 (missed sentence writing), Visuospatial: 1/1. Total = 3+4+3+3+1+7+1 = 22/30. This score falls in the mild impairment range (18-23). Recommended follow-up: neuropsychological evaluation, brain MRI, laboratory workup (B12, TSH, syphilis serology), and clinical monitoring with repeat MMSE in 6 months.

Related Medications

Common Mistakes

Mistake

Using MMSE alone to diagnose dementia type

Correction

MMSE is a global cognitive screen, not a diagnostic tool. It cannot differentiate between Alzheimer's disease, vascular dementia, Lewy body dementia, or frontotemporal dementia. Comprehensive clinical and neuropsychological evaluation is required.

Mistake

Applying standard cutoffs without age and education adjustment

Correction

MMSE scores are significantly influenced by age and education. Normative data stratified by age and education should be used. A score of 24 may be normal for an 80-year-old with 8 years of education but abnormal for a 60-year-old with 16 years of education.

Mistake

Using MMSE in patients with aphasia or sensory deficits

Correction

MMSE relies heavily on verbal responses and visual construction. In patients with aphasia, hearing loss, or visual impairment, consider alternative tools like the Modified MMSE (3MS) or the MoCA Blind.

Frequently Asked Questions

What is the difference between MMSE and MoCA?
The MMSE is less sensitive for mild cognitive impairment (MCI) compared to the MoCA (18% vs 90% sensitivity). The MoCA includes more executive function, language, and abstraction tasks. The MMSE is better established for tracking moderate-to-severe dementia progression. The MMSE is copyright-protected and requires licensing fees, while the MoCA is freely available for clinical use. Both take 5-10 minutes and score out of 30.
Is the MMSE free to use?
The MMSE is copyright-protected by Psychological Assessment Resources (PAR) and requires a licensing fee for routine clinical use in many settings. The original Folstein MMSE is in the public domain in some jurisdictions. Free alternatives include the MoCA, Mini-Cog, and the Montreal Cognitive Assessment for MCI screening.
How often should MMSE be repeated?
For dementia monitoring, MMSE is typically repeated every 6-12 months. An annual decline of 2-4 points is expected in Alzheimer's disease. More frequent testing (3-6 months) may be appropriate in early stages or after medication initiation. Less frequent testing is needed for stable patients.

References

  • Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198. PubMed
  • Arevalo-Rodriguez I, Smailagic N, Roqué-Figuls M, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;(3):CD010783. PubMed
  • National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers (NG97). NICE; 2018.
Medical Disclaimer: This calculator is intended for use by healthcare professionals for educational and clinical decision support purposes only. It is not a substitute for professional clinical judgment.
Call Us
WhatsApp